Page last updated: 2024-10-17

citric acid, anhydrous and Disease Models, Animal

citric acid, anhydrous has been researched along with Disease Models, Animal in 112 studies

Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"Astilbin (AS) has been confirmed to be an attractive candidate drug for psoriasis; however, the low oral absorption limits its further development and utilization."8.31Citric Acid Enhances the Activities of Astilbin on Psoriasis via Down-Regulation of ( Liu, L; Lu, C; Wu, Y; Zhao, R; Zhao, Y, 2023)
"Aluminum (Al) is a known neurotoxic element involved in the etiology of some serious neurodegenerative disorders such as Alzheimer disease (AD)."7.80Chronic exposure to aluminum and melatonin through the diet: neurobehavioral effects in a transgenic mouse model of Alzheimer disease. ( Colomina, MT; Di Paolo, C; Domingo, JL; Gómez, M; Reverte, I, 2014)
"The anti-tussive effect of the R-(+)- and S-(-)-enantiomers of benproperine was evaluated and compared with that of the racemate on cough induced by 7."7.72Anti-tussive activity of benproperine enantiomers on citric-acid-induced cough in conscious guinea-pigs. ( Chen, S; Kong, W; Li, W; Li, Y; Min, L; Zhong, D, 2004)
"Cough is a common and protective reflex, but persistent coughing is debilitating and impairs quality of life."6.71Theobromine inhibits sensory nerve activation and cough. ( Barnes, PJ; Belvisi, MG; Birrell, MA; Crispino, N; Korbonits, D; Korbonits, M; Patel, HJ; Usmani, OS, 2005)
"Cough was induced by inhalation of citric acid aerosol before and after exposure to oxygen."5.34Oral N-acetylcysteine reverses hyperoxia-related cough suppression in guinea pigs. ( Bartos, V; Brozmanova, M; Javorka, M; Masar, J; Plank, L; Plevkova, J; Tatar, M, 2007)
"Astilbin (AS) has been confirmed to be an attractive candidate drug for psoriasis; however, the low oral absorption limits its further development and utilization."4.31Citric Acid Enhances the Activities of Astilbin on Psoriasis via Down-Regulation of ( Liu, L; Lu, C; Wu, Y; Zhao, R; Zhao, Y, 2023)
"The data show that nicotinamide riboside, the most energy-efficient among NAD precursors, could be useful for treatment of heart failure, notably in the context of DCM, a disease with few therapeutic options."3.88Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy. ( Baczkó, I; Blanc, J; Brenner, C; Breton, M; Decaux, JF; Deloux, R; Diguet, N; Garnier, A; Gouge, A; Gressette, M; Lavery, GG; Li, Z; Manoury, B; Mericskay, M; Mougenot, N; Piquereau, J; Tannous, C; Trammell, SAJ; Zoll, J, 2018)
"The guinea pig sensitized by ovalbumin is the most widely used model to study cough experimentally, as the neurophysiology of the vagus nerve in the guinea pig is closest to humans."3.83The Guinea Pig Sensitized by House Dust Mite: A Model of Experimental Cough Studies. ( Buday, T; Gavliakova, S; Kavalcikova-Bogdanova, N; Medvedova, I; Mokry, J; Plevkova, J, 2016)
"The efficacy of H4R antagonist JNJ7777120 on nasal symptoms, cough, airway resistance (Raw), inflammatory cell count in bronchoalveolar lavage (BAL) and blood in ovalbumin (OVA) induced allergic rhinitis (AR) was studied in guinea pigs."3.81The effect of selective antagonist of H4 receptor JNJ7777120 on nasal symptoms, cough, airway reactivity and inflammation in guinea pigs. ( Buday, T; Gavliakova, S; Kosutova, P; Kovacova-Hanuskova, E; Mokra, D; Mokry, J; Plevkova, J; Urbanova-Fulmekova, A, 2015)
"Aluminum (Al) is a known neurotoxic element involved in the etiology of some serious neurodegenerative disorders such as Alzheimer disease (AD)."3.80Chronic exposure to aluminum and melatonin through the diet: neurobehavioral effects in a transgenic mouse model of Alzheimer disease. ( Colomina, MT; Di Paolo, C; Domingo, JL; Gómez, M; Reverte, I, 2014)
"Exaggerated laryngeal chemoreflexes (LCR) have been implicated in the occurrence and prolongation of apnea in premature and term neonates."3.74Prolonged dynamic changes in autonomic heart rate modulation induced by acid laryngeal stimulation in non-sedated lambs. ( Beuchée, A; Branger, B; Carrault, G; Nsegbe, E; Pladys, P; Praud, JP; St Hilaire, M, 2007)
"The anti-tussive effect of the R-(+)- and S-(-)-enantiomers of benproperine was evaluated and compared with that of the racemate on cough induced by 7."3.72Anti-tussive activity of benproperine enantiomers on citric-acid-induced cough in conscious guinea-pigs. ( Chen, S; Kong, W; Li, W; Li, Y; Min, L; Zhong, D, 2004)
"Acetazolamide can produce severe lactic acidosis with an increased lactate-to-pyruvate ratio, ketosis with a low beta-hydroxybutyrate-to-acetoacetate ratio, and a urinary organic acid profile typical of pyruvate carboxylase deficiency."3.71Pathogenic mechanism, prophylaxis, and therapy of symptomatic acidosis induced by acetazolamide. ( Bagnoli, F; Filippi, L; Margollicci, M; Rubaltelli, FF; Tronchin, M; Zammarchi, E, 2002)
" Magnesium deficiency caused pure calcium phosphate tissue deposits, containing no magnesium, but no deposition of calcium oxalate in the tubular lumen; tissue magnesium, calcium and phosphorus were increased, and there was marked potassium wastage via urine; despite mild hypercalcemia other signs of hyperparathyroidism were not found."3.70Reappraisal of the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rat. Effects of treatment with potassium citrate or the combination magnesium citrate and potassium citrate. ( Bergé, B; Dvorak, O; Markovic, M; Schmiedl, A; Schwille, PO, 1998)
"Cough is a common and protective reflex, but persistent coughing is debilitating and impairs quality of life."2.71Theobromine inhibits sensory nerve activation and cough. ( Barnes, PJ; Belvisi, MG; Birrell, MA; Crispino, N; Korbonits, D; Korbonits, M; Patel, HJ; Usmani, OS, 2005)
" Prevention of NC with (low) oral doses of citrate has not resulted in a significant decrease in the prevalence of NC; a higher citrate dosage deserves further study."2.46Nephrocalcinosis in preterm neonates. ( Kist-van Holthe, JE; Schell-Feith, EA; van der Heijden, AJ, 2010)
"Ferric citrate (FC) is an approved therapy for chronic kidney disease (CKD) patients as a phosphate (Pi) binder for dialysis-dependent CKD, and for iron deficiency anemia (IDA) in non-dialysis CKD."1.72Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKD. ( Agoro, R; Allen, MR; Clinkenbeard, EL; Damrath, JG; Hum, JM; Liesen, MP; Ni, P; Noonan, ML; Swallow, EA; Wallace, JM; White, KE, 2022)
"Nonalcoholic fatty liver disease (NAFLD) and its evolution to inflammatory steatohepatitis (NASH) are the most common causes of chronic liver damage and transplantation that are reaching epidemic proportions due to the upraising incidence of metabolic syndrome, obesity, and diabetes."1.56Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. ( Albanese, C; Avantaggiati, ML; Catalina-Rodriguez, O; Cheema, A; Foley, P; Gadre, S; Giaccone, G; Graham, GT; Kallakury, B; Kasprzyk-Pawelec, A; Mosaoa, R; Parasido, E; Tan, M; Yi, C, 2020)
"Repeated cough may lead to airway remodeling, which was also associated with an increased frequency of cough."1.51Induction of airway remodeling and persistent cough by repeated citric acid exposure in a guinea pig cough model. ( Cui, S; Ito, I; Iwata, T; Izuhara, H; Kanemitsu, Y; Matsumoto, H; Mishima, M; Nagasaki, T; Nakaji, H; Niimi, A; Oguma, T; Tajiri, T, 2019)
"Hypoxic lactic acidosis was efficiently reversed in group PR, instead of group CR, (pH 7."1.48Pyruvate in reduced osmolarity oral rehydration salt corrected lactic acidosis in sever scald rats. ( Li, ZY; Liu, R; Wang, SM; Yu, W; Zhang, HP; Zhou, FQ, 2018)
" The production process did not release any detectable toxic substance but slightly reduced fibroblast proliferation in vitro."1.48Safety, osseointegration, and bone ingrowth analysis of PMMA-based porous cement on animal metaphyseal bone defect model. ( Barboza, WM; Brassesco, MS; Cimatti, B; Engel, EE; Nogueira-Barbosa, MH; Okano, LT; Santos, MAD, 2018)
"Stroke was induced in mice by middle cerebral artery occlusion for 90 minutes, followed by reperfusion."1.46Hepatic Ketogenesis Induced by Middle Cerebral Artery Occlusion in Mice. ( Berressem, D; Eckert, GP; Klein, J; Koch, K; Konietzka, J; Thinnes, A, 2017)
"Obesity is associated with tissue inflammation which is a crucial etiology of insulin resistance."1.43An Immunomodulatory Device Improves Insulin Resistance in Obese Porcine Model of Metabolic Syndrome. ( Buffington, DA; Humes, HD; Johnston, KA; Westover, AJ, 2016)
"Obstructive jaundice was induced in rats by double ligation and division of the common bile duct (BDL group)."1.42Expression of renal Oat5 and NaDC1 transporters in rats with acute biliary obstruction. ( Brandoni, A; Torres, AM, 2015)
"Cough was induced by adding citric acid (CA) to the tracheal perfusion in anaesthetized animals, or by inhaling 0."1.39The effects of nasal irritant induced responses on breathing and cough in anaesthetized and conscious animal models. ( Biringerova, Z; Brozmanova, M; Gavliakova, S; Hanuskova, E; Plevkova, J; Poliacek, I; Tatar, M, 2013)
" Next, we carried out a 7-day simultaneous treatment study by two daily treatments, that is, FYX-051 (6 mg/kg) and citrate (2,000 mg/kg), followed by citrate-alone treatment, under the conditions of selected dosing intervals, the second dose of citrate, and dosing volume."1.37Establishment of simultaneous treatment model with citrate for preventing nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats. ( Ashizawa, N; Matsumoto, K; Moto, M; Nagata, O; Shimo, T; Taniguchi, T, 2011)
"Prostate cancer is the second leading cause of cancer deaths among men."1.37Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model. ( Bok, R; Costello, LC; Feng, P; Franklin, RB; Kurhanewicz, J; Swanson, MG; Zou, J, 2011)
"Cough was elicited by inhalation of citric acid aerosols and evaluated at 30 min (early phase) or 24 h (late phase) after the 1st or 6th nasal challenge (NC) in the sensitized animals."1.34Experimental allergic rhinitis-related cough and airway eosinophilia in sensitized guinea pigs. ( Bartos, V; Brozmanova, M; Plank, L; Tatar, M, 2007)
"Cough was induced by inhalation of citric acid aerosol before and after exposure to oxygen."1.34Oral N-acetylcysteine reverses hyperoxia-related cough suppression in guinea pigs. ( Bartos, V; Brozmanova, M; Javorka, M; Masar, J; Plank, L; Plevkova, J; Tatar, M, 2007)
"Cough was induced by citric acid aerosol inhalation in gradually increasing concentration (0."1.33Antileukotriene treatment and allergic rhinitis-related cough in guinea pigs. ( Bartos, V; Brozmanova, M; Plank, L; Plevkova, J; Tatar, M, 2005)
"Cough was elicited by inhalation of citric acid aerosols."1.33Early and late allergic phase related cough response in sensitized guinea pigs with experimental allergic rhinitis. ( Bartos, V; Brozmanová, M; Calkovský, V; Plank, L; Plevková, J; Tatár, M, 2006)
" Airway hyperresponsiveness was evidenced by significant shifts to the left of dose-response curves for intravenous acetylcholine (ACh) without a change in maximum responses to ACh."1.29The tachykinin NK2 receptor antagonist SR 48968 inhibits citric acid-induced airway hyperresponsiveness in guinea pigs. ( Advenier, C; Emonds-Alt, X; Girard, V; Yavo, JC, 1996)

Research

Studies (112)

TimeframeStudies, this research(%)All Research%
pre-19904 (3.57)18.7374
1990's15 (13.39)18.2507
2000's32 (28.57)29.6817
2010's51 (45.54)24.3611
2020's10 (8.93)2.80

Authors

AuthorsStudies
Zhao, Y5
Liu, X5
Si, F1
Huang, L3
Gao, A1
Lin, W1
Hoft, DF1
Shao, Q1
Peng, G1
Liesen, MP1
Noonan, ML1
Ni, P1
Agoro, R1
Hum, JM1
Clinkenbeard, EL1
Damrath, JG1
Wallace, JM1
Swallow, EA1
Allen, MR1
White, KE1
Liu, L1
Wu, Y3
Lu, C1
Zhao, R2
Yuan, Z1
Tsou, YH1
Zhang, XQ1
Huang, S1
Yang, Y4
Gao, M2
Ho, W1
Zhao, Q1
Ye, X1
Xu, X3
Estevez, AY1
Ganesana, M1
Trentini, JF1
Olson, JE1
Li, G1
Boateng, YO1
Lipps, JM1
Yablonski, SER1
Donnelly, WT1
Leiter, JC1
Erlichman, JS1
Zhang, W2
Shen, Z1
Xing, Y1
Zhao, H1
Liang, Y1
Chen, J3
Zhong, X1
Shi, L1
Wan, X1
Zhou, J1
Tang, S1
Foucaud, L1
Demoulin, B1
Leblanc, AL1
Ioan, I1
Schweitzer, C1
Demoulin-Alexikova, S1
Tan, M1
Mosaoa, R1
Graham, GT1
Kasprzyk-Pawelec, A1
Gadre, S1
Parasido, E1
Catalina-Rodriguez, O1
Foley, P1
Giaccone, G1
Cheema, A1
Kallakury, B1
Albanese, C1
Yi, C1
Avantaggiati, ML1
Sterusky, M1
Plevkova, J8
Grendar, M1
Buday, T4
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Wang, J8
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X4
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y5
Liu, Z4
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J3
Zhang, C3
Chen, L2
Yang, X1
Li, W4
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y2
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C3
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y7
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X2
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y7
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X3
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J1
Wu, W2
Liu, Y8
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L2
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G3
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y3
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF2
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L2
Wang, L5
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y5
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S2
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J4
Guo, W2
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F2
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J3
Qi, N1
Shen, G2
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z3
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q2
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C5
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y3
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J3
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D2
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y3
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z3
Liang, H1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y2
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Ruan, Z1
Li, S5
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z5
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C2
Tang, Y1
Kong, X1
Lu, J1
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S2
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L2
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L2
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Ma, K1
Hu, X2
Que, W1
Ito, H2
Takahashi, K2
Nakajima, M2
Tanaka, T2
Ren, K1
Guo, WZ1
Yi, SQ1
Li, XK2
Kopel, JJ1
Bhutia, YD1
Sivaprakasam, S1
Ganapathy, V1
Lan, Y1
Zhu, W1
Duan, X1
Deng, T1
Wen, Y1
Zhao, Z1
Zeng, G1
Zhu, P1
Lin, Y1
Duan, Z2
Jia, L2
Gui, B2
Guo, N1
Dou, D1
Ran, X1
Koch, K1
Berressem, D1
Konietzka, J1
Thinnes, A1
Eckert, GP1
Klein, J1
Ren, JG1
Seth, P1
Ye, H1
Guo, K1
Hanai, JI1
Husain, Z1
Sukhatme, VP1
Trojan, BP1
Trojan, SJ1
Navetta, A1
Staches, B1
Sutton, B1
Filleur, S1
Nelius, T1
Abudu, H1
Aximujiang, K1
Ahemaiti, A1
Yunusi, K1
Liu, RZ1
Fan, CX1
Zhang, ZL1
Liu, HH1
Nie, ZX1
Pu, XP1
Chou, YL1
Mori, N1
Canning, BJ1
Diguet, N1
Trammell, SAJ1
Tannous, C1
Deloux, R1
Piquereau, J1
Mougenot, N1
Gouge, A1
Gressette, M1
Manoury, B1
Blanc, J1
Breton, M1
Decaux, JF1
Lavery, GG1
Baczkó, I1
Zoll, J1
Garnier, A1
Brenner, C1
Mericskay, M1
Rocha, M1
Arcanjo, R1
Lopes, C1
Carneiro, M1
Souza, A1
Báo, S1
Liu, R1
Wang, SM1
Li, ZY1
Yu, W1
Zhang, HP1
Zhou, FQ1
Yao, Z1
Ma, W1
Sun, XY1
Jia, S1
Qiu, Z1
Shi, C1
Ding, H1
Lv, H1
Xu, R1
Martino, GP1
Perez, CE1
Magni, C1
Blancato, VS1
Tian, X1
Kim, JP1
Ao, X1
Shan, D1
Lin, Q1
Hudock, MR1
Bai, X1
Cui, S1
Ito, I1
Nakaji, H1
Iwata, T1
Matsumoto, H1
Oguma, T1
Tajiri, T1
Nagasaki, T1
Kanemitsu, Y1
Izuhara, H1
Mishima, M1
Niimi, A1
Zhuang, J1
Gao, X1
Biringerova, Z1
Gavliakova, S3
Brozmanova, M5
Tatar, M6
Hanuskova, E1
Poliacek, I1
Ishii, K1
Sugimoto, T1
Kanazawa, T1
Yoneda, Y1
Kamikawa, S1
Limori, H1
Nakatani, T1
Yamamoto, K1
Kishimoto, T1
Alex, M1
Sauganth Paul, MV1
Abhilash, M1
Mathews, VV1
Anilkumar, TV1
Nair, RH1
Di Paolo, C1
Reverte, I1
Colomina, MT1
Domingo, JL1
Gómez, M1
Dodd, MS1
Atherton, HJ1
Carr, CA1
Stuckey, DJ1
West, JA1
Griffin, JL1
Radda, GK1
Clarke, K1
Heather, LC1
Tyler, DJ1
Sasaki, Y1
Kohjimoto, Y1
Iba, A1
Matsumura, N1
Hara, I1
Krieger, NS1
Asplin, JR1
Frick, KK1
Granja, I1
Culbertson, CD1
Ng, A1
Grynpas, MD1
Bushinsky, DA1
LaConti, JJ1
Laiakis, EC1
Mays, AD1
Peran, I1
Kim, SE1
Shay, JW1
Riegel, AT1
Fornace, AJ1
Wellstein, A1
Kovacova-Hanuskova, E1
Kosutova, P1
Mokra, D1
Urbanova-Fulmekova, A1
Mokry, J3
Yao, G1
Zhu, D1
Fu, R1
Ge, H1
Tian, L1
Brandoni, A1
Torres, AM1
Fernández-Blanco, JA1
Aguilera, M1
Domènech, A1
Tarrasón, G1
Prats, N1
Miralpeix, M1
De Alba, J1
Surapaneni, KM1
Vishnu Priya, V1
Mallika, J1
Bielarczyk, H1
Jankowska-Kulawy, A1
Höfling, C1
Ronowska, A1
Gul-Hinc, S1
Roßner, S1
Schliebs, R1
Pawelczyk, T1
Szutowicz, A1
Medvedova, I1
Kavalcikova-Bogdanova, N1
Yokoyama, KK1
Lin, CL1
Chen, TY1
Hsiao, HW1
Chiang, PC1
Hsu, C1
Westover, AJ1
Johnston, KA1
Buffington, DA2
Humes, HD2
Al-Ani, B1
Fitzpatrick, M1
Al-Nuaimi, H1
Coughlan, AM1
Hickey, FB1
Pusey, CD1
Savage, C1
Benton, CM1
O'Brien, EC1
O'Toole, D1
Mok, KH1
Young, SP1
Little, MA1
Kovacikova, L1
Ruzinak, R1
Cimatti, B1
Santos, MAD1
Brassesco, MS1
Okano, LT1
Barboza, WM1
Nogueira-Barbosa, MH1
Engel, EE1
Schell-Feith, EA1
Kist-van Holthe, JE1
van der Heijden, AJ1
Yang, XZ1
Zhu, JY1
Tang, CP1
Ke, CQ1
Lin, G1
Cheng, TY1
Rudd, JA1
Ye, Y1
Kim, SH1
Yang, SO1
Kim, HS2
Park, T1
Choi, HK1
Li, M1
Ling, KH1
Lam, H1
Shaw, PC1
Cheng, L1
Techen, N1
Khan, LA1
Chang, YS1
But, PP1
Inoue, H1
Someno, T1
Kawada, M1
Ikeda, D1
Kim, KB1
Yang, JY1
Kwack, SJ1
Park, KL1
Ryu, DH1
Kim, YJ1
Hwang, GS1
Lee, BM1
Ashizawa, N1
Shimo, T1
Matsumoto, K1
Taniguchi, T1
Moto, M1
Nagata, O1
El-Hashim, AZ1
Edafiogho, IO1
Jaffal, SM1
Yousif, MH1
Ezeamuzie, CI1
Kombian, SB1
Costello, LC1
Franklin, RB1
Zou, J1
Feng, P1
Bok, R1
Swanson, MG1
Kurhanewicz, J1
Franova, S1
Joskova, M1
Sadlonova, V1
Pavelcikova, D1
Mesarosova, L1
Novakova, E1
Sutovska, M1
Pino, CJ1
Farokhrani, A1
Lou, L1
Smith, PL1
Johnston, K1
Griffiths, EJ1
Hu, G1
Fries, B1
Caza, M1
Gsponer, J1
Gates-Hollingsworth, MA1
Kozel, TR1
De Repentigny, L1
Kronstad, JW1
Tanaka, M3
Kawamoto, S1
Maruyama, K3
Vincent, G1
Khairallah, M1
Bouchard, B1
Des Rosiers, C1
Shabahang, S1
Bohsali, K1
Boyne, PJ1
Caplanis, N1
Lozada, J1
Torabinejad, M1
Poljak-Blazi, M1
Hrvacić, B1
Zupanović, Z1
Hadzija, M1
Stanić, B1
Polancec, D1
Min, L1
Zhong, D1
Kong, W1
Sucu, N1
Tamer, L1
Aytacoglu, B1
Polat, A1
Dondas, HA1
Gul, A1
Dikmengil, M1
Atik, U1
Usmani, OS1
Belvisi, MG2
Patel, HJ1
Crispino, N1
Birrell, MA1
Korbonits, M1
Korbonits, D1
Barnes, PJ1
Akira, K1
Imachi, M1
Hashimoto, T1
Bartos, V4
Plank, L4
Calkovský, V1
Minamizawa, K1
Goto, H1
Shimada, Y1
Terasawa, K1
Haji, A1
Motrich, RD1
Maccioni, M1
Ponce, AA1
Gatti, GA1
Oberti, JP1
Rivero, VE1
Mack, WJ1
Mocco, J1
Ducruet, AF1
Laufer, I1
King, RG1
Pinsky, DJ1
Connolly, ES1
Lewis, CA1
Ambrose, C1
Banner, K1
Battram, C1
Butler, K1
Giddings, J1
Mok, J1
Nasra, J1
Winny, C1
Poll, C1
Beuchée, A1
Nsegbe, E1
St Hilaire, M1
Carrault, G1
Branger, B1
Pladys, P1
Praud, JP2
Morice, AH1
Fontana, GA1
Birring, SS1
Chung, KF1
Dicpinigaitis, PV1
Kastelik, JA1
McGarvey, LP1
Smith, JA1
Widdicombe, J1
St-Hilaire, M1
Samson, N1
Duvareille, C1
Javorka, M1
Masar, J1
Nosalova, G1
Karasulu, HY1
Sanal, ZE1
Sözer, S1
Güneri, T1
Ertan, G1
Hirshman, CA2
Downes, H1
Leon, DA1
Peters, JE1
Lönnerdal, B1
Keen, CL1
Hurley, LS1
Elliott, EJ1
Watson, AJ1
Walker-Smith, JA1
Farthing, MJ1
Girard, V1
Yavo, JC1
Emonds-Alt, X1
Advenier, C1
Blomlöf, J1
Jansson, L1
Blomlöf, L2
Lindskog, S2
Güngör, F1
Karayalçin, B1
Gültekin, M1
Paksoy, N1
Sentürk, UK1
Kaputlu, I1
Yildiz, A1
Erkiliç, M1
Sorvari, R1
Pelttari, A1
Meurman, JH1
Howdieshell, TR1
Gay, M1
DiPiro, JT1
Mooney, S1
Duvall, R1
Eckles, S1
Baisden, R1
Gupta, R1
Gupta, S1
Joshi, K1
Ganguly, NK1
Schmiedl, A1
Schwille, PO1
Bergé, B1
Markovic, M1
Dvorak, O1
Ricciardolo, FL2
Rado, V1
Fabbri, LM1
Sterk, PJ1
Di Maria, GU1
Geppetti, P1
Iguchi, M1
Takamura, C1
Umekawa, T1
Kurita, T1
Kohri, K2
Tanner, GA1
Vijayalakshmi, K1
Tanner, JA1
Yasui, T1
Sato, M1
Fujita, K1
Tozawa, K1
Nomura, S1
Arieff, AI1
Massry, SG1
Yagi, Y1
Kuwahara, M1
Nanji, A1
Birumachi, J1
Nishibata, R1
Mikami, H1
Tsubone, H1
Karwowski, AS1
MacLeod, BA1
Quastel, DM1
Filippi, L1
Bagnoli, F1
Margollicci, M1
Zammarchi, E1
Tronchin, M1
Rubaltelli, FF1
Mohanakumar, KP1
Thomas, B1
Sharma, SM1
Muralikrishnan, D1
Chowdhury, R1
Chiueh, CC1
Selvam, R1
Kurien, TB1
Pfister, RR1
Haddox, JL1
Yuille-Barr, D1
Berty, RM1
Adler, S1
Berg, JO1
Austin, DR1
Klein, W1
Hanifin, JM1
Hulbert, W1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Speech Therapy in the Management of Difficult-to-treat Chronic Cough[NCT03457610]30 participants (Actual)Interventional2016-01-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

6 reviews available for citric acid, anhydrous and Disease Models, Animal

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Consequences of NaCT/SLC13A5/mINDY deficiency: good versus evil, separated only by the blood-brain barrier.
    The Biochemical journal, 2021, 02-12, Volume: 478, Issue:3

    Topics: Animals; Blood-Brain Barrier; Bone and Bones; Citric Acid; Citric Acid Cycle; Dental Enamel; Diabete

2021
Nephrocalcinosis in preterm neonates.
    Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:2

    Topics: Animals; Calcium Oxalate; Citric Acid; Disease Models, Animal; Female; Gestational Age; Humans; Infa

2010
Zinc binding ligands and complexes in zinc metabolism.
    Advances in nutritional research, 1984, Volume: 6

    Topics: Acrodermatitis; Animals; Bile; Carrier Proteins; Cattle; Cattle Diseases; Chromatography, High Press

1984
Mechanisms of citric acid-induced bronchoconstriction.
    The American journal of medicine, 2001, Dec-03, Volume: 111 Suppl 8A

    Topics: Airway Resistance; Animals; Asthma; Bronchial Diseases; Capsaicin; Citric Acid; Constriction, Pathol

2001
Nitric oxide: an antioxidant and neuroprotector.
    Annals of the New York Academy of Sciences, 2002, Volume: 962

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Citric Acid; Disease Models, An

2002

Trials

2 trials available for citric acid, anhydrous and Disease Models, Animal

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Theobromine inhibits sensory nerve activation and cough.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:2

    Topics: Adult; Animals; Antitussive Agents; Capsaicin; Citric Acid; Codeine; Cough; Cross-Over Studies; Dise

2005

Other Studies

105 other studies available for citric acid, anhydrous and Disease Models, Animal

ArticleYear
Citrate Promotes Excessive Lipid Biosynthesis and Senescence in Tumor Cells for Tumor Therapy.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:1

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Citric Acid; Disease Models, Ani

2022
Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKD.
    Physiological reports, 2022, Volume: 10, Issue:11

    Topics: Animals; Citric Acid; Disease Models, Animal; Electrolytes; Ferric Compounds; Fibroblast Growth Fact

2022
Citric Acid Enhances the Activities of Astilbin on Psoriasis via Down-Regulation of
    Molecular pharmaceutics, 2023, 04-03, Volume: 20, Issue:4

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Citric Acid; Disease Models, Anima

2023
Injectable Citrate-Based Hydrogel as an Angiogenic Biomaterial Improves Cardiac Repair after Myocardial Infarction.
    ACS applied materials & interfaces, 2019, Oct-23, Volume: 11, Issue:42

    Topics: Animals; Biocompatible Materials; Cell Adhesion; Cell Proliferation; Citric Acid; Disease Models, An

2019
Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTA.
    Biomolecules, 2019, 10-03, Volume: 9, Issue:10

    Topics: Animals; Antioxidants; Catalase; Cell Death; Cerium; Citric Acid; Disease Models, Animal; Edetic Aci

2019
MiR-106a-5p modulates apoptosis and metabonomics changes by TGF-β/Smad signaling pathway in cleft palate.
    Experimental cell research, 2020, 01-15, Volume: 386, Issue:2

    Topics: Animals; Apoptosis; Cell Membrane; Citric Acid; Cleft Palate; Disease Models, Animal; Embryo, Mammal

2020
Modulation of protective reflex cough by acute immune driven inflammation of lower airways in anesthetized rabbits.
    PloS one, 2019, Volume: 14, Issue:12

    Topics: Administration, Inhalation; Anesthesia; Animals; Bronchoalveolar Lavage Fluid; Citric Acid; Cough; D

2019
Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.
    Cell death and differentiation, 2020, Volume: 27, Issue:7

    Topics: Acetyl Coenzyme A; Animals; Blood Glucose; Carrier Proteins; Cell Polarity; Citric Acid; Diet, High-

2020
Female Guinea Pig Model for Cough Studies and Its Response to Most Common Tussive Substances.
    Physiological research, 2020, 03-27, Volume: 69, Issue:Suppl 1

    Topics: Acrolein; Animals; Capsaicin; Citric Acid; Cough; Disease Models, Animal; Female; Guinea Pigs; Male;

2020
5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.
    Drug discoveries & therapeutics, 2021, Jan-23, Volume: 14, Issue:6

    Topics: Alanine Transaminase; Aminolevulinic Acid; Animals; Aspartate Aminotransferases; Citric Acid; Cytoki

2021
Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate.
    Journal of cellular physiology, 2021, Volume: 236, Issue:10

    Topics: Animals; Antiporters; Calcium Oxalate; Case-Control Studies; Cell Line; Citric Acid; Crystallization

2021
5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model.
    International immunopharmacology, 2021, Volume: 96

    Topics: Aminolevulinic Acid; Animals; B-Lymphocytes; Blood Urea Nitrogen; Body Weight; CD8-Positive T-Lympho

2021
Citrate attenuates vascular calcification in chronic renal failure rats.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2017, Volume: 125, Issue:5

    Topics: Animals; Aorta; Calcium Chelating Agents; Citric Acid; Disease Models, Animal; Histocytochemistry; K

2017
Metabolomics analysis of anaphylactoid reaction reveals its mechanism in a rat model.
    Asian Pacific journal of allergy and immunology, 2017, Volume: 35, Issue:4

    Topics: Allergens; Anaphylaxis; Animals; Arachidonic Acid; Citric Acid; Disease Models, Animal; Histamine; H

2017
Hepatic Ketogenesis Induced by Middle Cerebral Artery Occlusion in Mice.
    Journal of the American Heart Association, 2017, Apr-05, Volume: 6, Issue:4

    Topics: 3-Hydroxybutyric Acid; Adrenergic beta-Antagonists; Animals; Brain; Brain Ischemia; Citric Acid; Die

2017
Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway.
    Scientific reports, 2017, 07-03, Volume: 7, Issue:1

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cisplatin; Citric Acid; Citric Acid Cycle; Cytokines;

2017
Novel porcine model for calcium oxalate stone formation.
    International urology and nephrology, 2017, Volume: 49, Issue:10

    Topics: Ammonium Chloride; Animals; Blood Urea Nitrogen; Calcium Oxalate; Citric Acid; Creatinine; Disease M

2017
[Metabonomic analysis of the urine from rat model with abnormal sapra syndrome].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2017, Oct-28, Volume: 42, Issue:10

    Topics: Amino Acids; Animals; Citric Acid; Creatine; Disease Models, Animal; Energy Metabolism; Glutamine; G

2017
Effects of Dl-3-n-butylphthalide on Cerebral Ischemia Infarction in Rat Model by Mass Spectrometry Imaging.
    International journal of molecular sciences, 2017, Nov-22, Volume: 18, Issue:11

    Topics: Adenosine Triphosphate; Animals; Benzofurans; Brain Ischemia; Citric Acid; Disease Models, Animal; G

2017
Opposing effects of bronchopulmonary C-fiber subtypes on cough in guinea pigs.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2018, 03-01, Volume: 314, Issue:3

    Topics: Action Potentials; Adenosine; Animals; Bradykinin; Citric Acid; Cough; Disease Models, Animal; Guine

2018
Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.
    Circulation, 2018, 05-22, Volume: 137, Issue:21

    Topics: Acrylamides; AMP-Activated Protein Kinases; Animals; Cardiomyopathy, Dilated; Citric Acid; Cytokines

2018
Modulation of fibronectin and laminin expression by Rhodium (II) citrate-coated maghemite nanoparticles in mice bearing breast tumor.
    Scientific reports, 2017, 12-20, Volume: 7, Issue:1

    Topics: Animals; Breast; Breast Neoplasms; Cell Line, Tumor; Citric Acid; Disease Models, Animal; Extracellu

2017
Pyruvate in reduced osmolarity oral rehydration salt corrected lactic acidosis in sever scald rats.
    The Journal of surgical research, 2018, Volume: 226

    Topics: Acidosis, Lactic; Administration, Oral; Animals; Bicarbonates; Burns; Citric Acid; Disease Models, A

2018
Magnesium Citrate Protects Against Vascular Calcification in an Adenine-induced Chronic Renal Failure Rat Model.
    Journal of cardiovascular pharmacology, 2018, Volume: 72, Issue:6

    Topics: Actins; Adenine; Alkaline Phosphatase; Animals; Aorta; Aortic Diseases; Calcium; Cardiovascular Agen

2018
Association of cough hypersensitivity with tracheal TRPV1 activation and neurogenic inflammation in a novel guinea pig model of citric acid-induced chronic cough.
    The Journal of international medical research, 2018, Volume: 46, Issue:7

    Topics: Administration, Inhalation; Animals; Bronchi; Chronic Disease; Citric Acid; Cough; Disease Models, A

2018
Metabolic Response in Rabbit Urine to Occurrence and Relief of Unilateral Ureteral Obstruction.
    Journal of proteome research, 2018, 09-07, Volume: 17, Issue:9

    Topics: Acetic Acid; Alanine; Analysis of Variance; Animals; Biomarkers; Citric Acid; Creatinine; Disease Mo

2018
Implications of the expression of Enterococcus faecalis citrate fermentation genes during infection.
    PloS one, 2018, Volume: 13, Issue:10

    Topics: Animals; Bacterial Proteins; Carboxy-Lyases; Carrier Proteins; Citric Acid; Disease Models, Animal;

2018
Citrate-based materials fuel human stem cells by metabonegenic regulation.
    Proceedings of the National Academy of Sciences of the United States of America, 2018, 12-11, Volume: 115, Issue:50

    Topics: Adenosine Triphosphate; Animals; Biocompatible Materials; Biopolymers; Bone Regeneration; Cell Adhes

2018
Induction of airway remodeling and persistent cough by repeated citric acid exposure in a guinea pig cough model.
    Respiratory physiology & neurobiology, 2019, Volume: 263

    Topics: Administration, Inhalation; Airway Remodeling; Animals; Antitussive Agents; Basement Membrane; Citri

2019
An advanced recording and analysis system for the differentiation of guinea pig cough responses to citric acid and prostaglandin E2 in real time.
    PloS one, 2019, Volume: 14, Issue:5

    Topics: Acoustics; Aerosols; Animals; Citric Acid; Cough; Dinoprostone; Disease Models, Animal; Guinea Pigs;

2019
The effects of nasal irritant induced responses on breathing and cough in anaesthetized and conscious animal models.
    Respiratory physiology & neurobiology, 2013, Dec-01, Volume: 189, Issue:3

    Topics: Administration, Intranasal; Anesthesia; Animals; Anticoagulants; Antitussive Agents; Citric Acid; Co

2013
Effect of sodium pentosan polysulfate and citrate on urinary stone formation in hyperoxaluric rats.
    International journal of urology : official journal of the Japanese Urological Association, 1996, Volume: 3, Issue:1 Suppl

    Topics: Animals; Anticoagulants; Citric Acid; Disease Models, Animal; Hyperoxaluria; Male; Pentosan Sulfuric

1996
Astaxanthin modulates osteopontin and transforming growth factor β1 expression levels in a rat model of nephrolithiasis: a comparison with citrate administration.
    BJU international, 2014, Volume: 114, Issue:3

    Topics: Animals; Chelating Agents; Citric Acid; Disease Models, Animal; Down-Regulation; Immunohistochemistr

2014
Chronic exposure to aluminum and melatonin through the diet: neurobehavioral effects in a transgenic mouse model of Alzheimer disease.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014, Volume: 69

    Topics: Aluminum; Alzheimer Disease; Animals; Anti-Anxiety Agents; Citric Acid; Diet; Disease Models, Animal

2014
Impaired in vivo mitochondrial Krebs cycle activity after myocardial infarction assessed using hyperpolarized magnetic resonance spectroscopy.
    Circulation. Cardiovascular imaging, 2014, Volume: 7, Issue:6

    Topics: Acetylcarnitine; Animals; Biomarkers; Citric Acid; Citric Acid Cycle; Disease Models, Animal; Female

2014
Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome.
    International journal of urology : official journal of the Japanese Urological Association, 2015, Volume: 22, Issue:4

    Topics: Animals; Blood Glucose; Body Weight; Calcium Oxalate; Cholesterol; Citric Acid; Diabetes Mellitus; D

2015
Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:12

    Topics: Animals; Calcium; Calcium Oxalate; Calcium Phosphates; Calcium, Dietary; Citric Acid; Disease Models

2015
Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
    BMC genomics, 2015, Volume: 16 Suppl 1

    Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Citrate (si)-Synthase; Cit

2015
The effect of selective antagonist of H4 receptor JNJ7777120 on nasal symptoms, cough, airway reactivity and inflammation in guinea pigs.
    Respiratory physiology & neurobiology, 2015, Sep-15, Volume: 216

    Topics: Airway Resistance; Aluminum Hydroxide; Animals; Bronchoalveolar Lavage Fluid; Citric Acid; Cough; Di

2015
Citrate Attenuates Adenine-Induced Chronic Renal Failure in Rats by Modulating the Th17/Treg Cell Balance.
    Inflammation, 2016, Volume: 39, Issue:1

    Topics: Adenine; Animals; Anti-Inflammatory Agents; Blood Urea Nitrogen; Cell Survival; Citric Acid; Creatin

2016
Expression of renal Oat5 and NaDC1 transporters in rats with acute biliary obstruction.
    World journal of gastroenterology, 2015, Aug-07, Volume: 21, Issue:29

    Topics: Animals; Bilirubin; Biomarkers; Cholestasis, Extrahepatic; Citric Acid; Common Bile Duct; Dicarboxyl

2015
Enhanced cough reflex in a model of bleomycin-induced lung fibrosis in guinea pigs.
    Clinical science (London, England : 1979), 2015, Volume: 129, Issue:12

    Topics: Animals; Bleomycin; Brain-Derived Neurotrophic Factor; Bronchoalveolar Lavage Fluid; Capsaicin; Citr

2015
Effect of pioglitazone, quercetin, and hydroxy citric acid on vascular endothelial growth factor messenger RNA (VEGF mRNA) expression in experimentally induced nonalcoholic steatohepatitis (NASH).
    Turkish journal of medical sciences, 2015, Volume: 45, Issue:3

    Topics: Analysis of Variance; Animals; Antioxidants; Calcium Chelating Agents; Citric Acid; Disease Models,

2015
AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    Journal of Alzheimer's disease : JAD, 2015, Volume: 48, Issue:4

    Topics: Acetyl Coenzyme A; Acetylcholine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Pre

2015
The Guinea Pig Sensitized by House Dust Mite: A Model of Experimental Cough Studies.
    Advances in experimental medicine and biology, 2016, Volume: 905

    Topics: Airway Resistance; Animals; Citric Acid; Cough; Disease Models, Animal; Guinea Pigs; Immunization; M

2016
Knockout of ho-1 protects the striatum from ferrous iron-induced injury in a male-specific manner in mice.
    Scientific reports, 2016, 05-20, Volume: 6

    Topics: Animals; Apoptosis; Cerebral Hemorrhage; Citric Acid; Corpus Striatum; Disease Models, Animal; Estra

2016
An Immunomodulatory Device Improves Insulin Resistance in Obese Porcine Model of Metabolic Syndrome.
    Journal of diabetes research, 2016, Volume: 2016

    Topics: Animals; Citric Acid; Disease Models, Animal; Extracorporeal Circulation; Immunomodulation; Inflamma

2016
Changes in urinary metabolomic profile during relapsing renal vasculitis.
    Scientific reports, 2016, 12-01, Volume: 6

    Topics: Animals; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Citric Acid; Disease Models, An

2016
TRPV4 antagonist GSK2193874 does not modulate cough response to osmotic stimuli.
    Respiratory physiology & neurobiology, 2017, Volume: 236

    Topics: Animals; Citric Acid; Cough; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs;

2017
Safety, osseointegration, and bone ingrowth analysis of PMMA-based porous cement on animal metaphyseal bone defect model.
    Journal of biomedical materials research. Part B, Applied biomaterials, 2018, Volume: 106, Issue:2

    Topics: Animals; Bone Cements; Bone Substitutes; Bone Transplantation; Cell Line; Cell Survival; Citric Acid

2018
Alkaloids from roots of Stemona sessilifolia and their antitussive activities.
    Planta medica, 2009, Volume: 75, Issue:2

    Topics: 4-Butyrolactone; Alkaloids; Animals; Antitussive Agents; Azepines; Citric Acid; Cough; Disease Model

2009
1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet.
    Analytical and bioanalytical chemistry, 2009, Volume: 395, Issue:4

    Topics: Acetoacetates; Acetone; Animals; Betaine; Citric Acid; Dietary Fats; Disease Models, Animal; Glycine

2009
Cardiocrinum seeds as a replacement for Aristolochia fruits in treating cough.
    Journal of ethnopharmacology, 2010, Jul-20, Volume: 130, Issue:2

    Topics: Animals; Antitussive Agents; Aristolochia; Base Sequence; Citric Acid; Cough; Disease Models, Animal

2010
Citric acid inhibits a bacterial ceramidase and alleviates atopic dermatitis in an animal model.
    The Journal of antibiotics, 2010, Volume: 63, Issue:10

    Topics: Animals; Cell Line, Tumor; Ceramidases; Ceramides; Citric Acid; Dermatitis, Atopic; Disease Models,

2010
Toxicometabolomics of urinary biomarkers for human gastric cancer in a mouse model.
    Journal of toxicology and environmental health. Part A, 2010, Volume: 73, Issue:21-22

    Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Cell Line, Tumor; Citric Acid; Discriminant Analysis; Di

2010
Establishment of simultaneous treatment model with citrate for preventing nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats.
    Drug and chemical toxicology, 2011, Volume: 34, Issue:2

    Topics: Animals; Chelating Agents; Citric Acid; Disease Models, Animal; Enzyme Inhibitors; Kidney Diseases;

2011
Anti-tussive and bronchodilator mechanisms of action for the enaminone E121.
    Life sciences, 2011, Sep-12, Volume: 89, Issue:11-12

    Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Airway Obstruction; Aniline Compounds; Anim

2011
Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model.
    Cancer biology & therapy, 2011, Dec-15, Volume: 12, Issue:12

    Topics: Adenocarcinoma; Animals; Cation Transport Proteins; Citric Acid; Disease Models, Animal; Genetic The

2011
Experimental model of allergic asthma.
    Advances in experimental medicine and biology, 2013, Volume: 756

    Topics: Airway Resistance; Animals; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Citric Acid;

2013
Selective cytopheretic inhibitory device with regional citrate anticoagulation and portable sorbent dialysis.
    Artificial organs, 2013, Volume: 37, Issue:2

    Topics: Animals; Anticoagulants; Biomarkers; Biomimetic Materials; Citric Acid; Disease Models, Animal; Extr

2013
A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans.
    Molecular microbiology, 2012, Volume: 86, Issue:6

    Topics: Acetyl Coenzyme A; Amino Acid Sequence; Animals; ATP Citrate (pro-S)-Lyase; Cell Line; Citric Acid;

2012
[Coughing model by microinjection of citric acid into the larynx in guinea pig].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2002, Volume: 120, Issue:4

    Topics: Animals; Citric Acid; Cough; Disease Models, Animal; Guinea Pigs; Larynx; Male; Microinjections; Rat

2002
Metabolic phenotyping of the diseased rat heart using 13C-substrates and ex vivo perfusion in the working mode.
    Molecular and cellular biochemistry, 2003, Volume: 242, Issue:1-2

    Topics: Animals; Carbon Isotopes; Citric Acid; Disease Models, Animal; Energy Metabolism; In Vitro Technique

2003
Effect of teeth with periradicular lesions on adjacent dental implants.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2003, Volume: 96, Issue:3

    Topics: Acid Etching, Dental; Analysis of Variance; Animals; Bicuspid; Bone Density; Citric Acid; Dental Imp

2003
Differing effects of two iron compounds on experimental arthritis, TNF-alpha levels and immune response in mice.
    International immunopharmacology, 2003, Volume: 3, Issue:13-14

    Topics: Animals; Arthritis, Experimental; Autoimmunity; Cell Division; Cells, Cultured; Citric Acid; Disease

2003
Cough reflex induced by microinjection of citric acid into the larynx of guinea pigs: new coughing model.
    Journal of pharmacological sciences, 2003, Volume: 93, Issue:4

    Topics: Animals; Citric Acid; Cough; Disease Models, Animal; Guinea Pigs; Larynx; Male; Microinjections

2003
Anti-tussive activity of benproperine enantiomers on citric-acid-induced cough in conscious guinea-pigs.
    The Journal of pharmacy and pharmacology, 2004, Volume: 56, Issue:2

    Topics: Animals; Antitussive Agents; Benzhydryl Compounds; Citric Acid; Cough; Disease Models, Animal; Dose-

2004
Inhibition of calcification with citric acid in pericardial bioprosthetic heart valve material: a preliminary report.
    The Journal of heart valve disease, 2004, Volume: 13, Issue:4

    Topics: Animals; Bioprosthesis; Calcinosis; Calcium; Cattle; Chelating Agents; Citric Acid; Disease Models,

2004
Mechanisms of capsaicin- and citric-acid-induced cough reflexes in guinea pigs.
    Journal of pharmacological sciences, 2005, Volume: 99, Issue:1

    Topics: Animals; Capsaicin; Citric Acid; Cough; Disease Models, Animal; Drug Interactions; Guinea Pigs; Irri

2005
Investigations into biochemical changes of genetic hypertensive rats using 1H nuclear magnetic resonance-based metabonomics.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:5

    Topics: Animals; Citric Acid; Creatine; Creatinine; Dimethylamines; Disease Models, Animal; Hypertension; Ke

2005
Antileukotriene treatment and allergic rhinitis-related cough in guinea pigs.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2005, Volume: 56 Suppl 4

    Topics: Acetates; Administration, Oral; Animals; Citric Acid; Cough; Cyclopropanes; Disease Models, Animal;

2005
Early and late allergic phase related cough response in sensitized guinea pigs with experimental allergic rhinitis.
    Physiological research, 2006, Volume: 55, Issue:5

    Topics: Allergens; Animals; Citric Acid; Cough; Disease Models, Animal; Guinea Pigs; Immunization; Male; Nas

2006
Effects of eppikahangeto, a Kampo formula, and Ephedrae herba against citric acid-induced laryngeal cough in guinea pigs.
    Journal of pharmacological sciences, 2006, Volume: 101, Issue:2

    Topics: Animals; Antitussive Agents; Citric Acid; Cough; Disease Models, Animal; Dose-Response Relationship,

2006
Pathogenic consequences in semen quality of an autoimmune response against the prostate gland: from animal models to human disease.
    Journal of immunology (Baltimore, Md. : 1950), 2006, Jul-15, Volume: 177, Issue:2

    Topics: Animals; Autoimmune Diseases; Biomarkers; Citric Acid; Cytokines; Disease Models, Animal; Down-Regul

2006
A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased cerebral ascorbic acid and inhibited lipid peroxidation after murine reperfused stroke.
    Neurosurgery, 2006, Volume: 59, Issue:2

    Topics: Animals; Antioxidants; Ascorbic Acid; Brain Ischemia; Cerebral Cortex; Cerebral Infarction; Citric A

2006
Animal models of cough: literature review and presentation of a novel cigarette smoke-enhanced cough model in the guinea-pig.
    Pulmonary pharmacology & therapeutics, 2007, Volume: 20, Issue:4

    Topics: Animals; Antitussive Agents; Area Under Curve; Atropine; Capsaicin; Citric Acid; Codeine; Cough; Dis

2007
Prolonged dynamic changes in autonomic heart rate modulation induced by acid laryngeal stimulation in non-sedated lambs.
    Neonatology, 2007, Volume: 91, Issue:2

    Topics: Animals; Animals, Newborn; Apnea; Blood Pressure; Chemoreceptor Cells; Citric Acid; Disease Models,

2007
ERS guidelines on the assessment of cough.
    The European respiratory journal, 2007, Volume: 29, Issue:6

    Topics: Aerosols; Animals; Antitussive Agents; Capsaicin; Citric Acid; Clinical Trials as Topic; Cough; Dise

2007
Laryngeal stimulation by an acid solution in the pre-term lamb.
    Advances in experimental medicine and biology, 2008, Volume: 605

    Topics: Aging; Animals; Animals, Newborn; Citric Acid; Disease Models, Animal; Gastroesophageal Reflux; Hydr

2008
Experimental allergic rhinitis-related cough and airway eosinophilia in sensitized guinea pigs.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2007, Volume: 58 Suppl 5, Issue:Pt 1

    Topics: Aerosols; Animals; Bronchi; Citric Acid; Cough; Disease Models, Animal; Eosinophilia; Guinea Pigs; L

2007
Oral N-acetylcysteine reverses hyperoxia-related cough suppression in guinea pigs.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2007, Volume: 58 Suppl 5, Issue:Pt 1

    Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Citric Acid; Cough; Disease Models, Ani

2007
Evaluation of the cough reflex and airway reactivity in toluene- and ovalbumin-induced airway hyperresponsiveness.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2007, Volume: 58 Suppl 5, Issue:Pt 1

    Topics: Airway Resistance; Animals; Bronchial Provocation Tests; Bronchoconstriction; Bronchoconstrictor Age

2007
Permeation studies of indomethacin from different emulsions for nasal delivery and their possible anti-inflammatory effects.
    AAPS PharmSciTech, 2008, Volume: 9, Issue:2

    Topics: Administration, Intranasal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cetomacro

2008
Basenji-greyhound dog model of asthma: pulmonary responses after beta-adrenergic blockade.
    Journal of applied physiology: respiratory, environmental and exercise physiology, 1981, Volume: 51, Issue:6

    Topics: Adrenergic beta-Antagonists; Aerosols; Airway Resistance; Animals; Asthma; Citrates; Citric Acid; Di

1981
Bicarbonate and citrate in oral rehydration therapy: studies in a model of secretory diarrhea.
    Journal of pediatric gastroenterology and nutrition, 1993, Volume: 16, Issue:3

    Topics: Animals; Antacids; Bicarbonates; Cholera Toxin; Citrates; Citric Acid; Diarrhea; Disease Models, Ani

1993
The tachykinin NK2 receptor antagonist SR 48968 inhibits citric acid-induced airway hyperresponsiveness in guinea pigs.
    American journal of respiratory and critical care medicine, 1996, Volume: 153, Issue:5

    Topics: Acetylcholine; Aerosols; Animals; Benzamides; Bronchial Hyperreactivity; Bronchoconstriction; Capsai

1996
Root surface etching at neutral pH promotes periodontal healing.
    Journal of clinical periodontology, 1996, Volume: 23, Issue:1

    Topics: Acid Etching, Dental; Animals; Bicuspid; Chelating Agents; Citrates; Citric Acid; Collagen; Connecti

1996
Comparison of Tc-99m HIG and Ga-67 citrate in the evaluation of bacterial abscess in a rat model.
    Annals of nuclear medicine, 1996, Volume: 10, Issue:1

    Topics: Abscess; Animals; Citrates; Citric Acid; Disease Models, Animal; Escherichia coli Infections; Evalua

1996
Surface ultrastructure of rat molar teeth after experimentally induced erosion and attrition.
    Caries research, 1996, Volume: 30, Issue:2

    Topics: Animals; Beverages; Citric Acid; Dental Enamel; Dentin; Disease Models, Animal; Disease Susceptibili

1996
Heparin versus citrate regional anticoagulation during autotransfusion in a porcine intra-abdominal hemorrhage model.
    The American surgeon, 1997, Volume: 63, Issue:11

    Topics: Animals; Anticoagulants; Blood Coagulation Factors; Blood Pressure; Blood Transfusion, Autologous; C

1997
Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis.
    Comparative immunology, microbiology and infectious diseases, 1997, Volume: 20, Issue:4

    Topics: Animals; Chelation Therapy; Chronic Disease; Citric Acid; Deferoxamine; Disease Models, Animal; Drug

1997
Reappraisal of the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rat. Effects of treatment with potassium citrate or the combination magnesium citrate and potassium citrate.
    Urologia internationalis, 1998, Volume: 61, Issue:2

    Topics: Animals; Calcium; Calcium Phosphates; Cathartics; Citric Acid; Disease Models, Animal; Diuretics; Dr

1998
Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide.
    American journal of respiratory and critical care medicine, 1999, Volume: 159, Issue:2

    Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Airway Resistance; Animals; Asthma; Benzami

1999
Inhibitory effects of female sex hormones on urinary stone formation in rats.
    Kidney international, 1999, Volume: 56, Issue:2

    Topics: Animals; Blotting, Northern; Calcium; Citric Acid; Crystallization; Disease Models, Animal; Estradio

1999
Effects of potassium citrate/citric acid intake in a mouse model of polycystic kidney disease.
    Nephron, 2000, Volume: 84, Issue:3

    Topics: Animals; Body Weight; Chelating Agents; Citric Acid; Disease Models, Animal; Diuretics; Female; Glom

2000
Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model.
    Urological research, 2001, Volume: 29, Issue:1

    Topics: Animals; Blotting, Northern; Chelating Agents; Cholecalciferol; Citric Acid; Disease Models, Animal;

2001
Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone.
    The Journal of clinical investigation, 1974, Volume: 53, Issue:2

    Topics: Acute Disease; Acute Kidney Injury; Animals; Bicarbonates; Brain; Calcium; Citric Acid; Creatinine;

1974
The difference in citric acid-induced cough in congenitally bronchial-hypersensitive (BHS) and bronchial-hyposensitive (BHR) guinea pigs.
    Experimental animals, 2001, Volume: 50, Issue:5

    Topics: Administration, Inhalation; Aerosols; Animals; Asthma; Citric Acid; Cough; Disease Models, Animal; G

2001
The development and evaluation of a new aerosol irritant assay with minimal animal stress.
    Pulmonary pharmacology & therapeutics, 2001, Volume: 14, Issue:6

    Topics: Aerosols; Animal Welfare; Animals; Asthma; Avoidance Learning; Biological Assay; Citric Acid; Diseas

2001
Pathogenic mechanism, prophylaxis, and therapy of symptomatic acidosis induced by acetazolamide.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2002, Volume: 50, Issue:2

    Topics: Acetazolamide; Acidosis, Lactic; Animals; Animals, Newborn; Carbonic Anhydrase Inhibitors; Citric Ac

2002
Restoration of antioxidants in liver by methionine feeding in experimental rat urolithiasis.
    Indian journal of biochemistry & biophysics, 1992, Volume: 29, Issue:4

    Topics: Animals; Antioxidants; Citrates; Citric Acid; Diet; Disease Models, Animal; Gallium; Lipid Peroxidat

1992
The combined effect of citrate/ascorbate treatment in alkali-injured rabbit eyes.
    Cornea, 1991, Volume: 10, Issue:2

    Topics: Alkalies; Animals; Antacids; Ascorbic Acid; Burns, Chemical; Citrates; Citric Acid; Corneal Ulcer; D

1991
In vivo and in vitro rat model for cyclosporine-induced proximal tubular toxicity.
    The Journal of laboratory and clinical medicine, 1991, Volume: 118, Issue:1

    Topics: Acetylglucosaminidase; Ammonia; Animals; Citrates; Citric Acid; Cyclosporins; Disease Models, Animal

1991
Cellular reactions in pulpal and periodontal tissues after periodontal wound debridement.
    Journal of clinical periodontology, 1990, Volume: 17, Issue:3

    Topics: Animals; Carbonates; Citrates; Citric Acid; Combined Modality Therapy; Dental Pulp; Dental Scaling;

1990
Increased metachromatic cells and lymphocytes in bronchoalveolar lavage fluid of dogs with airway hyperreactivity.
    The American review of respiratory disease, 1986, Volume: 133, Issue:3

    Topics: Animals; Body Fluids; Bronchi; Bronchial Provocation Tests; Bronchial Spasm; Citrates; Citric Acid;

1986